Iqvia Holdings (IQV) Share-based Compensation (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Share-based Compensation came in at $95.0 million in Q2 2026, up 58.33% year-over-year from $60.0 million in Q2 2025, and up 46.15% quarter-over-quarter from $65.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Share-based Compensation (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Share-based Compensation across 15 years of filings, most recently posting $95.0 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 58.33% year-over-year to $95.0 million; the TTM figure through Jun 2026 stood at $275.0 million (up 17.52% YoY), while the FY2025 annual figure was $247.0 million, up 19.9% from the prior year.
- Share-based Compensation came in at $95.0 million for Q2 2026 at Iqvia Holdings, up from $65.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $95.0 million in Q2 2026 to a low of $30.0 million in Q1 2022.
- Average Share-based Compensation over 5 years is $56.9 million, with a median of $55.5 million recorded in 2024.
- Year-over-year, Share-based Compensation jumped 150.0% in 2023 and slipped 25.33% in 2024.
- Over 5 years, Share-based Compensation stood at $58.0 million in 2022, then fell by 22.41% to $45.0 million in 2023, then rose by 6.67% to $48.0 million in 2024, then gained by 25.0% to $60.0 million in 2025, then jumped by 58.33% to $95.0 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $95.0 million in Q2 2026, $65.0 million in Q1 2026, and $60.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 95.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.35 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 18.46 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 19.78 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 12.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 7.60 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 6.25 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 530,728.82 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 91,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.00 Mn |
| Mar 31, 2026 | 65.00 Mn |
| Dec 31, 2025 | 60.00 Mn |
| Sep 30, 2025 | 55.00 Mn |
| Jun 30, 2025 | 60.00 Mn |
| Mar 31, 2025 | 72.00 Mn |
| Dec 31, 2024 | 48.00 Mn |
| Sep 30, 2024 | 54.00 Mn |
| Jun 30, 2024 | 48.00 Mn |
| Mar 31, 2024 | 56.00 Mn |
| Dec 31, 2023 | 45.00 Mn |
| Sep 30, 2023 | 47.00 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Mar 31, 2023 | 75.00 Mn |
| Dec 31, 2022 | 58.00 Mn |
| Sep 30, 2022 | 61.00 Mn |
| Jun 30, 2022 | 45.00 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Dec 31, 2021 | 42.00 Mn |
| Sep 30, 2021 | 48.00 Mn |